Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
salimjsr@gmail.com
Website: http://news.profitpickpath.com
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
Website: http://news.profitpickpath.com
Leave a Reply